{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T01:37:18Z","timestamp":1793497038178,"version":"4.5.0"},"reference-count":21,"publisher":"Federa\u00e7\u00e3o das Associa\u00e7\u00f5es de Ginecologia e Obstetr\u00edcia","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,10,23]]},"DOI":"10.61622\/rbgo\/2024rbgo83","type":"journal-article","created":{"date-parts":[[2024,10,24]],"date-time":"2024-10-24T13:37:53Z","timestamp":1729777073000},"source":"Crossref","is-referenced-by-count":3,"title":["Assessment of risk factors associated with post-molar gestational trophoblastic neoplasia: a retrospective cohort"],"prefix":"10.61622","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1076-2944","authenticated-orcid":false,"given":"Silvia Regina","family":"Piazzetta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6221-6358","authenticated-orcid":false,"given":"Karin Anspach","family":"Hoch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6198-5593","authenticated-orcid":false,"given":"Cristina Laguna","family":"Benetti-Pinto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3889-4778","authenticated-orcid":false,"given":"Daniela Angerame","family":"Yela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"47794","reference":[{"key":"key20241024133745_B1","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1002\/ijgo.12615","article-title":"Update on the diagnosis and management of gestational trophoblastic disease","volume":"143","author":"Ngan","year":"2018","unstructured":"Ngan HY, Seckl MJ, Berkowitz RS, Xiang Y, Golfier F, Sekharan PK, et al. Update on the diagnosis and management of gestational trophoblastic disease. Int J Gynaecol Obstet. 2018;143 Suppl 2:79-85. doi: 10.1002\/ijgo.12615","journal-title":"Int J Gynaecol Obstet"},{"key":"key20241024133745_B2","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.bpobgyn.2020.12.001","article-title":"Clinical presentation and diagnosis of gestational trophoblastic disease","volume":"74","author":"Lok","year":"2021","unstructured":"Lok C, Frijstein M, van Trommel N. Clinical presentation and diagnosis of gestational trophoblastic disease. Best Pract Res Clin Obstet Gynaecol. 2021;74:42-52. doi: 10.1016\/j.bpobgyn.2020.12.001","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"key20241024133745_B3","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.bpobgyn.2021.01.006","article-title":"Treatment of low-risk gestational trophoblastic neoplasia","volume":"74","author":"Winter","year":"2021","unstructured":"Winter MC. Treatment of low-risk gestational trophoblastic neoplasia. Best Pract Res Clin Obstet Gynaecol. 2021;74:67-80. doi: 10.1016\/j.bpobgyn.2021.01.006","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"key20241024133745_B4","doi-asserted-by":"crossref","first-page":"vi39e50","DOI":"10.1093\/annonc\/mdt345","article-title":"Gestational trophoblastic disease: ESMO Clinical Practice Guidelines for diagnosis, treatment, and follow-up","volume":"24","author":"Seckl","year":"2013","unstructured":"Seckl MJ, Sebire NJ, Fisher RA, Golfier F, Massuger L, Sessa C, et al. Gestational trophoblastic disease: ESMO Clinical Practice Guidelines for diagnosis, treatment, and follow-up. Ann Oncol. 2013;24 Suppl 6:vi39e50. doi: 10.1093\/annonc\/mdt345","journal-title":"Ann Oncol"},{"issue":"6","key":"key20241024133745_B5","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.ajog.2010.06.073","article-title":"Gestational trophoblastic disease I: epidemiology, pathology, clinical presentation and diagnosis of gestational trophoblastic disease, and management of hydatidiform mole","volume":"203","author":"Lurain","year":"2010","unstructured":"Lurain JR. Gestational trophoblastic disease I: epidemiology, pathology, clinical presentation and diagnosis of gestational trophoblastic disease, and management of hydatidiform mole. Am J Obstet Gynecol. 2010;203(6):531-9. doi: 10.1016\/j.ajog.2010.06.073","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"key20241024133745_B6","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0020-7292(02)00063-2","article-title":"FIGO staging for gestational trophoblastic neoplasia 2000","volume":"77","author":"FIGO Oncology Committee","year":"2002","unstructured":"FIGO Oncology Committee. FIGO staging for gestational trophoblastic neoplasia 2000. Int J Gynaecol Obstet. 2002;77(3):285-7. doi: 10.1016\/s0020-7292(02)00063-2","journal-title":"Int J Gynaecol Obstet"},{"issue":"6","key":"key20241024133745_B7","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1111\/j.1479-828X.2009.01085.x","article-title":"Analysis of risk factors for persistent gestational trophoblastic disease","volume":"49","author":"Khoo","year":"2009","unstructured":"Khoo SK, Baartz D, Sidhu M, Yip WL, Tripcony L. Analysis of risk factors for persistent gestational trophoblastic disease. Aust N Z J Obstet Gynaecol. 2009;49(6):657-9. doi: 10.1111\/j.1479-828X.2009.01085.x","journal-title":"Aust N Z J Obstet Gynaecol"},{"issue":"8","key":"key20241024133745_B8","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1055\/s-0042-1748974","article-title":"Clinical presentation, treatment outcomes, and resistance-related factors in South American women with low-risk post-molar gestational trophoblastic neoplasia","volume":"44","author":"Ram\u00edrez","year":"2022","unstructured":"Ram\u00edrez LA, Maest\u00e1 I, Bianconi MI, Jankilevich G, Otero S, Mej\u00eda CR, et al. Clinical presentation, treatment outcomes, and resistance-related factors in South American women with low-risk post-molar gestational trophoblastic neoplasia. Rev Bras Ginecol Obstet. 2022;44(8):746-54. doi: 10.1055\/s-0042-1748974","journal-title":"Rev Bras Ginecol Obstet"},{"issue":"2","key":"key20241024133745_B9","first-page":"53","article-title":"Conduta no tumor trofobl\u00e1stico gestacional: experi\u00eancia de 10 anos de um centro de refer\u00eancia","volume":"20","author":"Uberti","year":"2000","unstructured":"Uberti EM, Diestel MC, Guimar\u00e3es FE, Lacerda ME, Rosa MW, N\u00e1poli G, et al. Conduta no tumor trofobl\u00e1stico gestacional: experi\u00eancia de 10 anos de um centro de refer\u00eancia. Acta Oncol Bras. 2000;20(2):53-62.","journal-title":"Acta Oncol Bras"},{"issue":"5-6","key":"key20241024133745_B10","first-page":"254","article-title":"Complete hydatidiform mole in women aged 40 to 49 years","volume":"57","author":"Elias","year":"2012","unstructured":"Elias KM, Shoni M, Bernstein M, Goldstein DP, Berkowitz RS. Complete hydatidiform mole in women aged 40 to 49 years. J Reprod Med. 2012;57(5-6):254-8.","journal-title":"J Reprod Med"},{"issue":"2","key":"key20241024133745_B11","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1097\/AOG.0000000000004240","article-title":"Gestational trophoblastic disease: current evaluation and management","volume":"137","author":"Soper","year":"2021","unstructured":"Soper JT. Gestational trophoblastic disease: current evaluation and management. Obstet Gynecol. 2021;137(2):355-70. doi: 10.1097\/AOG.0000000000004240","journal-title":"Obstet Gynecol"},{"issue":"8","key":"key20241024133745_B12","first-page":"591","article-title":"Predictors of persistent disease in women with complete hydatidiform mole","volume":"41","author":"Ayhan","year":"1996","unstructured":"Ayhan A, Tuncer ZS, Halilzade H, K\u00fc\u00e7\u00fckali T. Predictors of persistent disease in women with complete hydatidiform mole. J Reprod Med. 1996;41(8):591-4.","journal-title":"J Reprod Med"},{"issue":"3","key":"key20241024133745_B13","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1097\/01.AOG.0000203431.95377.76","article-title":"Postevacuation hCG levels and risk of gestational trophoblastic neoplasia in women with complete molar pregnancy","volume":"107","author":"Wolfberg","year":"2006","unstructured":"Wolfberg AJ, Berkowitz RS, Goldstein DP, Feltmate C, Lieberman E. Postevacuation hCG levels and risk of gestational trophoblastic neoplasia in women with complete molar pregnancy. Obstet Gynecol. 2006;107(3):743. doi: 10.1097\/01.AOG.0000203431.95377.76","journal-title":"Obstet Gynecol"},{"issue":"3","key":"key20241024133745_B14","doi-asserted-by":"crossref","first-page":"334.e1","DOI":"10.1016\/j.ajog.2016.04.019","article-title":"Effect of race\/ethnicity on clinical presentation and risk of gestational trophoblastic neoplasia in patients with complete and partial molar pregnancy at a tertiary care referral center","volume":"215","author":"Gockley","year":"2016","unstructured":"Gockley AA, Joseph NT, Melamed A, Sun SY, Goodwin B, Bernstein M, et al. Effect of race\/ethnicity on clinical presentation and risk of gestational trophoblastic neoplasia in patients with complete and partial molar pregnancy at a tertiary care referral center. Am J Obstet Gynecol. 2016;215(3):334.e1-6. doi: 10.1016\/j.ajog.2016.04.019","journal-title":"Am J Obstet Gynecol"},{"key":"key20241024133745_B15","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.ygyno.2023.07.012","article-title":"The impact of the distance traveled between residence and gestational trophoblastic neoplasia reference center and clinical outcomes in Brazilian women","volume":"176","author":"Braga","year":"2023","unstructured":"Braga A, Lopes R, Campos V, Freitas F, Maest\u00e1 I, Sun SY, et al. The impact of the distance traveled between residence and gestational trophoblastic neoplasia reference center and clinical outcomes in Brazilian women. Gynecol Oncol. 2023;176:130-8. doi: 10.1016\/j.ygyno.2023.07.012","journal-title":"Gynecol Oncol"},{"issue":"3","key":"key20241024133745_B16","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.fertnstert.2015.06.001","article-title":"Postmolar gestational trophoblastic neoplasia: beyond the traditional risk factors","volume":"104","author":"Bakhtiyari","year":"2015","unstructured":"Bakhtiyari M, Mirzamoradi M, Kimyaiee P, Aghaie A, Mansournia MA, Ashrafi-Vand S, et al. Postmolar gestational trophoblastic neoplasia: beyond the traditional risk factors. Fertil Steril. 2015;104(3):649-54. doi: 10.1016\/j.fertnstert.2015.06.001","journal-title":"Fertil Steril"},{"issue":"3","key":"key20241024133745_B17","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.ygyno.2014.04.002","article-title":"Preoperative quality of life and surgical outcomes in gynecologic oncology patients: a new predictor of operative risk?","volume":"133","author":"Doll","year":"2014","unstructured":"Doll K, Snavely A, Kalinowski A, Irwin D, Bensen J, Bae-Jump V, et al. Preoperative quality of life and surgical outcomes in gynecologic oncology patients: a new predictor of operative risk? Gynecol Oncol. 2014;133(3):546-51. doi: 10.1016\/j.ygyno.2014.04.002","journal-title":"Gynecol Oncol"},{"issue":"2","key":"key20241024133745_B18","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1002\/sim.2929","article-title":"Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond","volume":"27","author":"Pencina","year":"2008","unstructured":"Pencina MJ, D\u2019Agostino RB, D\u2019Agostino RB Jr, Vasan RS. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med. 2008;27(2):157-72. doi: 10.1002\/sim.2929","journal-title":"Stat Med"},{"key":"key20241024133745_B19","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.ejogrb.2018.02.001","article-title":"Does a human chorionic gonadotropin level of over 20,000 IU\/L four weeks after uterine evacuation for complete hydatidiform mole constitute an indication for chemotherapy for gestational trophoblastic neoplasia?","volume":"223","author":"Braga","year":"2018","unstructured":"Braga A, Biscaro A, do Amaral Giordani JM, Viggiano M, Elias KM, Berkowitz RS, et al. Does a human chorionic gonadotropin level of over 20,000 IU\/L four weeks after uterine evacuation for complete hydatidiform mole constitute an indication for chemotherapy for gestational trophoblastic neoplasia? Eur J Obstet Gynecol Reprod Biol. 2018;223:50-5. doi: 10.1016\/j.ejogrb.2018.02.001","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"1","key":"key20241024133745_B20","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.ejogrb.2011.10.003","article-title":"Human chorionic gonadotrophin regression rate as a predictive factor of postmolar gestational trophoblastic neoplasm in high-risk hydatidiform mole: a case-control study","volume":"160","author":"Kim","year":"2012","unstructured":"Kim BW, Cho H, Kim H, Nam EJ, Kim SW, Kim S, et al. Human chorionic gonadotrophin regression rate as a predictive factor of postmolar gestational trophoblastic neoplasm in high-risk hydatidiform mole: a case-control study. Eur J Obstet Gynecol Reprod Biol. 2012;160(1):100-5. doi: 10.1016\/j.ejogrb.2011.10.003","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"4","key":"key20241024133745_B21","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1097\/AOG.0b013e31826af61a","article-title":"False alarms and pseudo-epidemics: the limitation of observational epidemiology","volume":"120","author":"Grimes","year":"2012","unstructured":"Grimes DA, Schulz KF. False alarms and pseudo-epidemics: the limitation of observational epidemiology. Obstet Gynecol. 2012;120(4):920-7. doi: 10.1097\/AOG.0b013e31826af61a","journal-title":"Obstet Gynecol"}],"container-title":["Revista Brasileira de Ginecologia e Obstetr\u00edcia"],"original-title":[],"language":"en","deposited":{"date-parts":[[2024,10,24]],"date-time":"2024-10-24T13:38:02Z","timestamp":1729777082000},"score":1,"resource":{"primary":{"URL":"https:\/\/journalrbgo.org\/article\/assessment-of-risk-factors-associated-with-post-molar-gestational-trophoblastic-neoplasia-a-retrospective-cohort\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"references-count":21,"alternative-id":["10.61622\/rbgo\/2024rbgo83"],"URL":"https:\/\/doi.org\/10.61622\/rbgo\/2024rbgo83","relation":{},"ISSN":["0100-7203","1806-9339"],"issn-type":[{"value":"0100-7203","type":"print"},{"value":"1806-9339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024]]},"article-number":"e-rbgo83"}}